Dr. Reddy’s Laboratories Limited reported Total Income for Q4 FY23 of ₹6,453.7 Crore up from ₹5,596.8 Crore year on year, a growth of 15.3%. Consolidated Net Profit of ₹960.1 Crore, surged from ₹97 Crore in the same quarter of the previous year. The Earnings per Share is ₹57.68, from ₹5.83 in the same quarter of the previous year.
Dr Reddy’s Laboratories Q4 FY23; Net Profit Surged Up To ₹960 Crore
Tags: pharmaceuticals
Related Post
- Pyramid Technoplast Limited reports Q3 FY26 volume-led growth; margins steady as new capacities ramp up
Pyramid Technoplast Limited (NSE: PYRAMID, BSE: 543969) reported moderate revenue growth in the December quarter,…
-
Dilip Buildcon Limited (NSE: DBL, BSE: 540047) reports Q3 FY26 results as order book hits record high
Dilip Buildcon Limited (NSE: DBL, BSE: 540047) reported its financial results for the quarter and…
-
Edelweiss Financial Services Limited charts multi-year growth across asset management and insurance businesses
Edelweiss Financial Services Limited (NSE: EDELWEISS, BSE: 532922) presented a multi-year snapshot of growth across…